Jupiter Endovascular

Jupiter Endovascular, Inc. is a privately held medical technology company headquartered in Menlo Park, California, developing Endoportal Control, a platform technology that fixes a flexibly navigated endoportal device into a stable state inside the vasculature so a catheter-based intervention can be delivered with the precision and control of direct surgical access. Its lead product is the Vertex Pulmonary Embolectomy System for acute pulmonary embolism, evaluated in the SPIRARE I first-in-human study (NCT06571760) and the FDA-approved SPIRARE II U.S. pivotal study. The company exited stealth with $21M and later closed an oversubscribed Series B surpassing its $40M target, led by Sonder Capital. Jupiter Endovascular is a pre-commercial clinical-stage device manufacturer and publishes no developer program, no API, and no machine-readable interface of any kind.

Jupiter Endovascular is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Medical Technology, Healthcare, and Interventional Cardiology.

6.9/100 minimal ▬ flat Agent 3/100 human only Full breakdown ↓
scored 2026-08-25 · rubric v0.14.0
0 APIs
CompanyMedical DevicesMedical TechnologyHealthcareInterventional CardiologyPulmonary EmbolismClinical Trials

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-25 · rubric v0.14.0
Composite quality — 6.9/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 1.8 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.9 / 9
Regulatory Posture 1.9 / 15
Agent readiness — 3/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 4 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Delegated User Identity 0 / 6
Protected Resource Metadata 0 / 5
Registration Without a Human 0 / 6
Agentic Commerce Surface 0 / 5
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/jupiter-endovascular: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Jupiter Endovascular Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Commercial 1

Pricing, plans, and the legal terms of use

Company 1

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: jupiter-endovascular
name: Jupiter Endovascular
description: Jupiter Endovascular, Inc. is a privately held medical technology company headquartered in Menlo Park, California,
  developing Endoportal Control, a platform technology that fixes a flexibly navigated endoportal device into a stable state
  inside the vasculature so a catheter-based intervention can be delivered with the precision and control of direct surgical
  access. Its lead product is the Vertex Pulmonary Embolectomy System for acute pulmonary embolism, evaluated in the SPIRARE
  I first-in-human study (NCT06571760) and the FDA-approved SPIRARE II U.S. pivotal study. The company exited stealth with
  $21M and later closed an oversubscribed Series B surpassing its $40M target, led by Sonder Capital. Jupiter Endovascular
  is a pre-commercial clinical-stage device manufacturer and publishes no developer program, no API, and no machine-readable
  interface of any kind.
url: https://raw.githubusercontent.com/api-evangelist/jupiter-endovascular/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-23'
modified: '2026-08-23'
tags:
- Company
- Medical Devices
- Medical Technology
- Healthcare
- Interventional Cardiology
- Pulmonary Embolism
- Clinical Trials
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/jupiter-endovascular-domain-security.yml
- type: Website
  url: https://jupiterendo.com/
- type: PrivacyPolicy
  url: https://jupiterendo.com/privacy-policy/
x-enrichment:
  date: '2026-08-23'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Jupiter Endovascular is a pre-commercial clinical-stage manufacturer of a physical Class III catheter device (the
    Vertex Pulmonary Embolectomy System, in the SPIRARE I and II trials) — software is not the product, and the only web property
    is a SiteGround-hosted WordPress marketing site at jupiterendo.com that answers every path, including a deliberately bogus
    control path, with an identical 202 sg-captcha interstitial; there is no GitHub organization, no package on npm or PyPI,
    and the api/developer/docs subdomains all wildcard to a NameBright parking host rather than to any developer surface.
  evidence:
  - url: https://jupiterendo.com/openapi.json
    status: 202
  - url: https://jupiterendo.com/.well-known/agent-card.json
    status: 202
  - url: https://api.github.com/orgs/jupiter-endovascular
    status: 404
  - url: https://registry.npmjs.org/jupiter-endovascular
    status: 404
  checked: '2026-08-23'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/jupiter-endovascular"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/jupiter-endovascular/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/jupiter-endovascular/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

A second provider on the same verified email joins the account you already have.